Basketball

Celtics guard Marcus Smart close to return after suffering 'gross' eye infection


Celtics guard Marcus Smart is on the upswing after a brutal case of viral conjunctivitis caused an infection in both of his eyes, sidelining him for much of December, reports ESPN’s Tim Bontemps

Smart isn’t playing today in Toronto, but thinks he’s at “about 80 percent” and is focused on getting his conditioning back to its usual level. 

Mostly, he’s relieved that the worst of his eye issues appear to be behind him.

“I thought I was going to go blind for a while. I think it was the worst case of viral conjunctivitis that they’ve seen,” Smart said. “… I couldn’t see. I had outdoor sunglasses everywhere. Even in the dark I was wearing sunglasses. It was that bad. Just every morning I would wake up just having sticky discharge coming out of my eyes, sealing my eyes shut. It was really just gross.”

With Celtics forward Gordon Hayward back in the lineup today, the Celtics appear close to getting fully healthy. In the meantime, let’s round up a few more notes out of Boston:

  • Although the Celtics look capable of vying for a spot in the NBA Finals, finding the last piece to cement their place as a contender will be difficult, according to Gary Washburn of The Boston Globe, who outlines why the club may not be able to make a significant trade this winter. We touched on a similar topic last week.
  • Terry Rozier is impressed with how former teammates Jaylen Brown and Jayson Tatum have looked this season, suggesting the two young wings are “superstars in the making,” as Steve Bulpett of The Boston Herald details. “I’m not just saying it. Them guys put the work in,” Rozier said. “They really care. They want to learn the game, and them boys can really play.”
  • Celtics big man Enes Kanter isn’t taking today’s game in Toronto for granted. Chris Forsberg of NBC Sports Boston explains why Kanter’s safety may be at risk when he travels outside the United States.





READ NEWS SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.